p.75 抽出テキスト
CLINICAL STATEMENTS AND GUIDELINES September 16, 2025 Circulation. 2025;152:e114–e218. DOI: 10.1161/CIR.0000000000001356 e188 REFERENCES Preamble 1. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine (US). Clinical Practice Guidelines We Can Trust. National Academies Press; 2011. 2. Committee on Standards for Systematic Reviews of Comparative Effective ness Research, Institute of Medicine (US). Finding What Works in Health care: Standards for Systematic Reviews. National Academies Press; 2011. 3. Anderson JL, Heidenreich PA, Barnett PG, et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Prac tice Guidelines. Circulation. 2014;129:2329–2345. 4. ACCF/AHA Task Force on Practice Guidelines. Methodology Manual and policies from the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology and American Heart Association. 2010. Accessed May 14, 2024. https://www.acc.org/Guidelines/About-Guidelines-and- Clinical-Documents/Methodology and https://professional.heart.org/-/ media/phd-files/guidelines-and-statements/methodology_manual_and_ policies_ucm_319826.pdf. 5. Halperin JL, Levine GN, Al-Khatib SM, et al. Further evolution of the ACC/ AHA clinical practice guideline recommendation classification system: a re port of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;133:1426– 1428. 6. Arnett DK, Goodman RA, Halperin JL, et al. AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardio vascular disease and comorbid conditions: from the American Heart Asso ciation, American College of Cardiology, and US Department of Health and Human Services. Circulation. 2014;130:1662–1667. 7. Levine GN, O’Gara PT, Beckman JA, et al. Recent innovations, modifications, and evolution of ACC/AHA clinical practice guidelines: an update for our constituencies: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e879–e886. Introduction 1. Khan SS, Matsushita K, Sang Y, et al. Development and validation of the American Heart Association’s PREVENT equations. Circulation. 2024;149:430–449. 2. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on life style management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S76–S99. 3. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American Col lege of Cardiology/American Heart Association Task Force on Practice Guide lines and The Obesity Society. Circulation. 2014;129(suppl 2):s102–s138. 4. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646. 5. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the Ameri can College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72–e227. 6. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guide line for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Prac tice Guidelines. Circulation. 2022;145:e895–e1032. 7. Isselbacher EM, Preventza O, Black JH 3rd, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the Ameri can Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146:e334–e482. 8. Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/ NLA/PCNA guideline for the management of patients with chronic coro nary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148:e9–e119. 9. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1–e156. 10 Gornik HL, Aronow HD, Goodney PP, et al. 2024 ACC/AHA/AACVPR/ APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the manage ment of lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024:149;e1313–e1410. 11. Thompson A, Fleischmann KE, Smilowitz NR, et al. 2024 AHA/ACC/ACS/ ASNC/HRS/SCA/SCCT/SCMR/SVM guideline for perioperative cardio vascular management for noncardiac surgery: a report of the American Col lege of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;150:e351–e442. 12. Burke LE, Ma J, Azar KM, et al. Current science on consumer use of mobile health for cardiovascular disease prevention: a scientific statement from the American Heart Association. Circulation. 2015;132:1157–1213. 13. Carey RM, Calhoun DA, Bakris GL, et al. Resistant hypertension: detec tion, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018;72:e53-e90. 14. Muntner P, Shimbo D, Carey RM, et al. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hy pertension. 2019;73:e35-e66. 15. Casey DE Jr, Thomas RJ, Bhalla V, et al. 2019 AHA/ACC clinical per formance and quality measures for adults with high blood pressure: a re port of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes. 2019;12:e000057. 16. Muntner P, Einhorn PT, Cushman WC, et al. Blood pressure assessment in adults in clinical practice and clinic-based research: JACC scientific expert panel. J Am Coll Cardiol. 2019;73:317–335. 17. Shimbo D, Artinian NT, Basile JN, et al. Self-measured blood pressure moni toring at home: a joint policy statement from the American Heart Associa tion and American Medical Association. Circulation. 2020;142:E42–E63. 18. Bhalla V, Textor SC, Beckman JA, et al. Revascularization for renovascular disease: a scientific statement from the American Heart Association. Hyper tension. 2022;79:e128-e143. 19. Choudhry NK, Kronish IM, Vongpatanasin W, et al. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension. 2022;79:e1-e14. 20. Takahashi EA, Schwamm LH, Adeoye OM, et al. An overview of telehealth in the management of cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2022;146:e558-e568. 21. Garovic VD, Dechend R, Easterling T, et al. Hypertension in pregnancy: di agnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension. 2022;79:e21-e41. 22. Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life's essential 8: up dating and enhancing the American Heart Association's construct of cardiovascular health: a Presidential Advisory from the American Heart As sociation. Circulation. 2022;146:e18-e43. 23. Kittleson MM, Panjrath GS, Amancherla K, et al. 2023 ACC expert con sensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023;81:1835–1878. 24. Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-kidneymetabolic health: a Presidential Advisory from the American Heart Associa tion. Circulation. 2023;148:1606–1635. 25. Khan SS, Coresh J, Pencina MJ, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148:1982–2004. 26. Abdalla M, Bolen SD, Brettler J, et al. Implementation strategies to improve blood pressure control in the United States: a scientific statement from the American Heart Association and American Medical Association. Hyperten sion. 2023;80:e143-e157. 27. Cluett JL, Blazek O, Brown AL, et al. Renal denervation for the treatment of hypertension: a scientific statement from the American Heart Association. Hypertension. 2024;81:e135-e148. 28. Methodology manual and policies from the ACCF/AHA Task Force on Prac tice Guidelines. American College of Cardiology and American Heart As sociation. 2010. Accessed June 3, 2020. https://professional.heart.org/-/ media/phd-files/guidelines-and-statements/methodology_manual_and_ policies_ucm_319826.pdf. 2.1 Definition of High Blood Pressure 1 Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. Downloaded from http://ahajournals.org by on October 7, 2026